相关实验视频

Updated: Jul 1, 2025

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

在CLL中使用BTK抑制剂:第二代药物及其他药物

Constantine Tam^1,2, Philip A Thompson^3,4

¹Department of Haematology, Alfred Hospital, Melbourne, VIC, Australia.

|March 13, 2024

概括

布鲁顿的氨酸激酶 (BTK) 抑制剂对于B细胞癌症至关重要. 新一代和降解剂的目标是克服耐药性,减少副作用,改善患者的治疗结果.

科学领域:

在瘤学瘤学.
药理学药理学是指药理学的学科.
血液学血液学血液学

背景情况:

布鲁顿的氨酸激酶抑制剂 (BTKis) 是B细胞恶性瘤的标准治疗方法.
第一代BTKi易布鲁丁尼布显示有效性,但有心血管方面的副作用.
第二代BTK提供了更好的选择性和更少的心血管并发症.

研究的目的:

审查BTK向疗法的演变.
讨论新出现的耐药性突变及其临床影响.
探索BTK抑制剂研发的未来方向.

主要方法:

对BTK抑制剂的临床试验和科学文献的审查.
对抗性机制的分析,包括C481S和非C481突变.
讨论新的治疗策略,如可逆BTKis和BTK降解剂.

主要成果:

比特基因已经从不可逆转的演变为可逆和可降解的.
心血管方面的副作用可以通过新一代BTKis减少.
新兴的耐药性突变 (非C481) 对当前和未来的疗法构成挑战.

结论:

持续的研究对于解决BTK抑制剂耐药性的问题至关重要.
对于B细胞恶性瘤,需要新的药物和治疗序列策略.
降解BTK的降解剂代表了对抗耐药突变的有希望的治疗途径.

更多相关视频

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.